期刊文献+

碳五馏分与加盐二甲基甲酰胺常压汽液平衡数据的测定及关联 被引量:2

Measurement and Correlation of Vapor-Liquid Equilibrium Data for C_5 Fraction and Salt-Containing Dimethylformamide at Atmospheric Pressure
下载PDF
导出
摘要 以二甲基甲酰胺(DMF)为溶剂,采用小型气相循环釜测定了NaCl,KNO_3,KCOOH,NaSCN,KSCN 5种盐对1-戊烯-异戊二烯物系相对挥发度的影响;在101.3 kPa下测定了碳五组分(异戊二烯、1-戊烯和环戊烯)与DMF+NaSCN 3组物系的汽液平衡数据。实验结果表明,加入NaSCN时,1-戊烯对异戊二烯相对挥发度的增幅最大,在DMF中NaSCN适宜的质量分数为4%;3组物系的汽液平衡数据符合热力学一致性检验。用NRTL模型对汽液平衡数据进行了关联,得到模型参数,汽相组成最大偏差为0.87%,温度的最大偏差为1.00 K。 Effects of NaCl, KNO3 , KCOOH, NaSCN and KSCN in dimethylformamide(DMF) as the solvent on the relative volatility of 1-pentene-isoprene system was measured. The salt-containing DMF could increase the relative volatilities of the 1-pentene-isoprene system, especially NaSCN- containing DMF with the suitable 4% mass fraction NaSCN. The vapor-liquid equilibrium(VLE) data of isoprene-DMF + NaSCN, 1 -pentene-DMF + NaSCN and cyclopentene-DMF + NaSCN were measured at 101.3 kPa, which were consistent with the thermodynamic consistency test. The obtained VLE data were correlated by NRTL equation and the model parameters were calculated. The maximal deviations of the vapor composition and the bubble point temperature were 0.87 % and 1.00 K, respectively.
出处 《石油化工》 CAS CSCD 北大核心 2011年第1期65-68,共4页 Petrochemical Technology
关键词 异戊二烯 1-戊烯 环戊烯 二甲基甲酰胺 汽液平衡 碳五馏分 isoprene 1-pentene cyclopentene dimethylformamide vapor-liquid equilibrium C5 fraction
  • 相关文献

参考文献13

二级参考文献24

共引文献53

同被引文献27

  • 1任守经 高秀峰 等.稀土催化剂的性质-添加不同结构的化合物对丁二烯聚合的影响[J].高分子通讯,1982,(6):435-435.
  • 2沈之荃 龚仲元 仲崇祺 等.稀土化合物在定向聚合中的催化活性.科学通报,1964,9(4):335-336.
  • 3沈之荃 欧阳均 龚仲元.稀土化合物在定向聚合中的催化活性.Ⅱ.稀土螯合物与三烷基铝组成的均相体系对丁二烯定向聚合的催化活性.高分子通讯,1965,7(3):193-200.
  • 4李东风,马立国.裂解碳五馏分分离技术的研究进展[J].石油化工,2007,36(8):755-762. 被引量:34
  • 5Reiter Y,Pastan I. Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis [ J ].Trends Biotech, 1998,16(12) :513 - 520.
  • 6Mendelsohn J. Epidermal growth factor receptor inhibition by a monoclonal antibody as antibody therapy [ J ]. Clin Cancer Res,1997,3(12 pt 2) :2703- 2707.
  • 7Brocchini S, Duncan R. Polymer drug conjugates: drug release from pendent linker[ A]. Mathiowitz E (ED). Encyclopaedia of controlled drug delivery[M]. New York:Wiley, 1999. 786 - 816.
  • 8Duncan R, Gac-Breton S, Keane R, et al. Polymer-drug conjugates,PDEPT and PELT:basic principles for design and transfer from the laboratory to clinic [ J ]. J Controlled Release, 2001,74(1- 3) :135- 146.
  • 9Garett MC. Targeted drug conjugates: principles and progress[J]. Adv Drug Deliev Rev ,2001,53(2): 171 - 216.
  • 10Yeh MY, Roffler SR. Doxorubicin: monoclonal antibody conjugate for therapy of human cervical carcinoma[ J ]. Int J Cancer,1992,51 (2) :274 - 282.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部